Document is current
Any future updates will be listed below
-
Authors
López-Villarreal, Ana
Sánchez-Morla, Eva María https://orcid.org/0000-0002-9438-2307
Jiménez-López, Estela
Martínez-Vizcaíno, Vicente
Aparicio, Ana Isabel
Mateo-Sotos, Jorge
Rodriguez-Jimenez, Roberto
Vieta, Eduard
Santos, José Luis
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI16/00359)
- License Information
-
More Information
Article History
Received: 3 February 2019
Accepted: 7 August 2019
First Online: 17 August 2019
Compliance with ethical standards
:
: Dr. R. Rodriguez-Jimenez has been a consultant for, spoken in activities of, or received grants from: Instituto de Salud Carlos III, Fondo de Investigación Sanitaria (FIS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid Regional Government (S2010/BMD-2422 AGES; B2017/BMD-3740 AGES CM 2-CM), JanssenCilag, Lundbeck, Otsuka, Pfizer, Ferrer, Juste, and Takeda. Dr. Vieta has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Allergan, Angelini, AstraZeneca, Bristol-Myers Squibb, Dainippon Sumitomo Pharma, Farmindustria, Ferrer, Forest Research Institute, Gedeon Richter, Glaxo-Smith-Kline, Janssen, Lundbeck, Otsuka, Pfizer, Roche, Sanofi-Aventis, Servier, Shire, Sunovion, Takeda, the Brain and Behaviour Foundation, the Spanish Ministry of Science and Innovation (CIBERSAM), the Seventh European Framework Programme (ENBREC), and the Stanley Medical Research Institute. All the other authors declare that they have no conflicts of interest.
